Researchers identify cause of post-COVID inflammatory shock in children

What is “kiss disease”. How dangerous can it be and what are the symptoms of this condition. Here's what specialists say.Most cases of infectious mononucleosis are caused by the Epstein-Barr virus. About 90% of the population becomes infected with this virus by the age of 30, but most people remain only carriers.What causes infectious mononucleosisUsually, children do not have visible symptoms of infectious mononucleosis. However, adolescents an…

Researchers identify cause of post-COVID inflammatory shock in children

MIS-C is a serious inflammatory shock that affects children. It can occur several weeks after a COVID infection and can be life-threatening.

The rare inflammatory reaction Pims can be life-threatening for children. Behind it is probably the re-ignition of a resting virus.

Doctors Uncover How a Dormant Virus Reactivates After COVID and Triggers Severe Illness in Kids

New research reveals that Epstein-Barr virus reactivation, triggered by COVID, may cause MIS-C in children. MIS-C is a severe inflammatory condition that can develop in children weeks after a COVID infection, sometimes with life-threatening consequences. Until now, its exact cause remained unclear. Researchers from Charité – Universitätsmedizin Berlin and the German Rheumatology Research Center (DRFZ), [...]

Immune molecule links COVID‑19 with severe inflammatory disorder in children

The immune molecule TGFβ has been found to weaken immune defences against latent viruses, triggering reactivation of the Epstein–Barr virus. This mechanism links TGFβ release in SARS-CoV-2 infection to multisystem inflammatory syndrome in children, and could inform the development of therapies for managing this serious condition. The molecule TGFβ suppresses the ability of T cells to protect against latent Epstein–Barr virus.

Age differences in prevalence and symptoms of post-COVID-19 condition among children: a prospective cohort study

Some individuals experience unexplained, persistent, or newly developed symptoms after coronavirus disease 2019 (COVID-19), known as post-COVID-19 conditio